Depressive symptoms during early adulthood and the development of physical multimorbidity in the UK: an observational cohort study.


Journal

The lancet. Healthy longevity
ISSN: 2666-7568
Titre abrégé: Lancet Healthy Longev
Pays: England
ID NLM: 101773309

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 14 12 2021
Statut: ppublish

Résumé

An understanding of whether early-life depression is associated with physical multimorbidity could be instrumental for the development of preventive measures and the integrated management of depression. We therefore aimed to map out the cumulative incidence of physical multimorbidity over adulthood, and to determine the association between the presence of depressive symptoms during early adulthood and the development of physical multimorbidity in middle age. In this observational cohort study, we used pooled data from the 1958 National Child Development Study (NCDS) and the 1970 British Cohort Study (BCS). Cohort waves were pooled in each decade of adult life available (when cohort members were aged 26 years in the BCS and 23 years in the NCDS [baseline]; 34 years in the BCS and 33 years in the NCDS [age 34 BCS/33 NCDS]; 42 years in the BCS and NCDS [age 42 BCS/NCDS]; and 46 years in the BCS and 50 years in the NCDS [age 46 BCS/50 NCDS]). We included participants who had completed the nine-item Malaise Inventory at baseline, and did not have a history of physical multimorbidity, any physical multimorbidity at baseline, or the presence of depressive symptoms before the development of physical multimorbidity. The presence of depressive symptoms was determined using the nine-item Malaise Inventory (cutoff score ≥4). Physical multimorbidity was defined as having at least two measures of any of the following ten self-reported groups of long-term conditions: asthma or bronchitis; backache; bladder or kidney conditions; cancer; cardiovascular conditions; convulsions or epilepsy; diabetes; hearing conditions; migraine; and stomach, bowel, or gall conditions. Cumulative incidence (with 95% CI) of physical multimorbidity was calculated for each decade considered after baseline, with physical multimorbidity being assessed as both a dichotomous and categorical variable. The association between depressive symptoms and the development of physical multimorbidity was assessed using adjusted relative risk ratios (with 95% CIs). Analyses included 15 845 participants, of whom 4001 (25·25%; 95% CI 24·57-25·93) had depressive symptoms at baseline and 11 844 (74·75%; 74·07-75·42) did not. The cumulative incidence of physical multimorbidity (dichotomous) ranged over the study period from 2263 (18·44%; 95% CI 17·75-18·14) of 12 273 participants at age 34 BCS/33 NCDS, to 4496 (42·90%; 41·95-43·85) of 10 481 participants at age 46 BCS/50 NCDS, and was consistently higher in participants with depressive symptoms at baseline. The adjusted relative risk of physical multimorbidity was higher in participants with depressive symptoms than in those without and remained stable over the study period (adjusted relative rate ratio 1·67, 95% CI 1·50-1·87, at age 34 BCS/33 NCDS; 1·63, 1·48-1·79, at age 42 BCS/NCDS; and 1·58, 1·43-1·73, at age 46 BCS/50 NCDS). The presence of depressive symptoms during early adulthood is associated with an increased risk of the development of physical multimorbidity in middle age. Although further research about the drivers of this relationship is needed, these results could help to enhance the integrated management of individuals with depressive symptoms and the development of preventive strategies to reduce the effect and burden of physical multimorbidity. UK Medical Research Council and Guy's Charity.

Sections du résumé

BACKGROUND
An understanding of whether early-life depression is associated with physical multimorbidity could be instrumental for the development of preventive measures and the integrated management of depression. We therefore aimed to map out the cumulative incidence of physical multimorbidity over adulthood, and to determine the association between the presence of depressive symptoms during early adulthood and the development of physical multimorbidity in middle age.
METHODS
In this observational cohort study, we used pooled data from the 1958 National Child Development Study (NCDS) and the 1970 British Cohort Study (BCS). Cohort waves were pooled in each decade of adult life available (when cohort members were aged 26 years in the BCS and 23 years in the NCDS [baseline]; 34 years in the BCS and 33 years in the NCDS [age 34 BCS/33 NCDS]; 42 years in the BCS and NCDS [age 42 BCS/NCDS]; and 46 years in the BCS and 50 years in the NCDS [age 46 BCS/50 NCDS]). We included participants who had completed the nine-item Malaise Inventory at baseline, and did not have a history of physical multimorbidity, any physical multimorbidity at baseline, or the presence of depressive symptoms before the development of physical multimorbidity. The presence of depressive symptoms was determined using the nine-item Malaise Inventory (cutoff score ≥4). Physical multimorbidity was defined as having at least two measures of any of the following ten self-reported groups of long-term conditions: asthma or bronchitis; backache; bladder or kidney conditions; cancer; cardiovascular conditions; convulsions or epilepsy; diabetes; hearing conditions; migraine; and stomach, bowel, or gall conditions. Cumulative incidence (with 95% CI) of physical multimorbidity was calculated for each decade considered after baseline, with physical multimorbidity being assessed as both a dichotomous and categorical variable. The association between depressive symptoms and the development of physical multimorbidity was assessed using adjusted relative risk ratios (with 95% CIs).
FINDINGS
Analyses included 15 845 participants, of whom 4001 (25·25%; 95% CI 24·57-25·93) had depressive symptoms at baseline and 11 844 (74·75%; 74·07-75·42) did not. The cumulative incidence of physical multimorbidity (dichotomous) ranged over the study period from 2263 (18·44%; 95% CI 17·75-18·14) of 12 273 participants at age 34 BCS/33 NCDS, to 4496 (42·90%; 41·95-43·85) of 10 481 participants at age 46 BCS/50 NCDS, and was consistently higher in participants with depressive symptoms at baseline. The adjusted relative risk of physical multimorbidity was higher in participants with depressive symptoms than in those without and remained stable over the study period (adjusted relative rate ratio 1·67, 95% CI 1·50-1·87, at age 34 BCS/33 NCDS; 1·63, 1·48-1·79, at age 42 BCS/NCDS; and 1·58, 1·43-1·73, at age 46 BCS/50 NCDS).
INTERPRETATION
The presence of depressive symptoms during early adulthood is associated with an increased risk of the development of physical multimorbidity in middle age. Although further research about the drivers of this relationship is needed, these results could help to enhance the integrated management of individuals with depressive symptoms and the development of preventive strategies to reduce the effect and burden of physical multimorbidity.
FUNDING
UK Medical Research Council and Guy's Charity.

Identifiants

pubmed: 34901908
doi: 10.1016/S2666-7568(21)00259-2
pii: S2666-7568(21)00259-2
pmc: PMC8636278
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e801-e810

Subventions

Organisme : Medical Research Council
ID : MR/S028188/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P020372/1
Pays : United Kingdom

Informations de copyright

© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Déclaration de conflit d'intérêts

MH is the principal investigator of the RADAR-CNS programme, a precompetitive public private partnership funded by the Innovative Medicines Initiative and European Federation of Pharmaceutical Industries and Associations. The programme receives support from Janssen, Biogen, Merck Sharp & Dohme, UCB, and Lundbeck. All other authors declare no competing interests.

Références

Neurol Clin. 2019 Nov;37(4):631-649
pubmed: 31563224
PLoS Med. 2018 Mar 6;15(3):e1002503
pubmed: 29509768
Br J Psychiatry. 2004 Jan;184:28-33
pubmed: 14702224
J Clin Psychiatry. 2014 Nov;75(11):1202-8; quiz 1208
pubmed: 25470083
J Psychosom Res. 2018 Oct;113:30-36
pubmed: 30190045
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
J Am Geriatr Soc. 2018 Jul;66(6):1101-1107
pubmed: 29603724
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
Lancet Public Health. 2020 Mar;5(3):e140-e149
pubmed: 32007134
Psychother Psychosom. 2018;87(5):308-310
pubmed: 30114682
Eur Psychiatry. 2008 Sep;23(6):421-9
pubmed: 18504118
J Clin Epidemiol. 2014 Mar;67(3):254-66
pubmed: 24472295
Br J Psychiatry. 2021 Jan 13;:1-3
pubmed: 33436108
Lancet Public Health. 2021 Oct;6(10):e729-e738
pubmed: 33961802
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
J Affect Disord. 2010 Jun;123(1-3):222-9
pubmed: 19880190
J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):301-11
pubmed: 21112963
Mech Ageing Dev. 2020 Dec;192:111383
pubmed: 33045250
Lancet Public Health. 2021 Aug;6(8):e587-e597
pubmed: 34166630
Ann Transl Med. 2020 Mar;8(6):299
pubmed: 32355743
Ann Fam Med. 2012 Mar-Apr;10(2):142-51
pubmed: 22412006
Int J Epidemiol. 2006 Aug;35(4):836-43
pubmed: 16931528
Am J Epidemiol. 2019 Sep 1;188(9):1627-1636
pubmed: 31274148
JAMA Psychiatry. 2020 Jun 1;77(6):598-606
pubmed: 31995135
Psychol Med. 2021 Jan 21;:1-10
pubmed: 33472020
PLoS Med. 2018 Mar 6;15(3):e1002513
pubmed: 29509757
Health Psychol. 2019 Sep;38(9):812-821
pubmed: 31144827
Brain Behav Immun. 2020 Aug;88:908-912
pubmed: 31972338
JAMA Psychiatry. 2021 Jan 1;78(1):38-46
pubmed: 32997099
Soc Psychiatry Psychiatr Epidemiol. 1999 Jun;34(6):333-41
pubmed: 10422488
Nat Commun. 2014 Jun 24;5:4022
pubmed: 24959948
J Behav Health Serv Res. 2011 Jul;38(3):373-82
pubmed: 21293976
Br J Gen Pract. 2018 Apr;68(669):e245-e251
pubmed: 29530918
J Comorb. 2019 Aug 22;9:2235042X19870934
pubmed: 31489279
Ann Fam Med. 2018 Jul;16(4):322-329
pubmed: 29987080
Health Psychol. 2019 Sep;38(9):791-801
pubmed: 31436464
Lancet. 2018 Jun 9;391(10137):2302
pubmed: 29573869
Lancet Public Health. 2020 Jan;5(1):e42-e50
pubmed: 31837974
Age Ageing. 2019 Nov 1;48(6):789-796
pubmed: 31579908

Auteurs

Jorge Arias-de la Torre (J)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Institute of Biomedicine, University of Leon, Leon, Spain.

Amy Ronaldson (A)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Matthew Prina (M)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Faith Matcham (F)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Snehal M Pinto Pereira (SM)

Institute of Sport, Exercise and Health, Faculty of Medical Sciences, University College London, London, UK.

Stephani L Hatch (SL)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
ESRC Centre for Society and Mental Health, King's College London, London, UK.

David Armstrong (D)

Department of Primary Care and Public Health Sciences, King's College London, London, UK.

Andrew Pickles (A)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Matthew Hotopf (M)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust, London, UK.

Alex Dregan (A)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH